Heart Eye Diagnostics Limited, a UK-based company, has announced the launch of Dr.Noon CVD, an advan...

Opus Genetics has reached a significant milestone in its ongoing Phase 1/2 clinical trial for OPGx-L...

Seonix Bio has launched SightScore in the United States, marking the first commercially available cl...

Opthea Limited has reached a significant milestone in its COAST Phase 3 clinical trial, completing t...

Alcon has announced the full U.S. commercial launch of Voyager DSLT, the first and only direct selec...

Telefónica is set to showcase its latest 5G and Artificial Intelligence (AI) healthcare innovations ...

GenSight Biologics has announced the final efficacy and safety results from its Phase 3 REFLECT clin...

MediPrint Ophthalmics has announced significant progress in its glaucoma drug delivery program follo...

Virtual Vision Health has announced the launch of visual acuity testing on its innovative Virtual Ey...

OKYO Pharma has announced that its lead investigational asset, OK-101, has been officially assigned ...